Bailard, Inc. Magenta Therapeutics, Inc. Transaction History

Bailard, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 10, 2020	SELL	$6.52 - $8.94 $130,399 - $178,800	-20,000 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$6.18 - $10.76 $49,440 - $86,080	-8,000 Reduced 28.57%	20,000 $150,000
Q1 2020 Apr 16, 2020	BUY	$6.03 - $15.24 $84,420 - $213,360	14,000 Added 100.0%	28,000 $176,000
Q4 2019 Jan 31, 2020	BUY	$9.07 - $15.84 $126,980 - $221,760	14,000 New	14,000 $212,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.